Feb 19, 2016 08:24 PM EST
Clot-Busting Drug Lowers Death Risk In This Group Of Stroke Survivors
The clot-busting drug Alteplase, a tissue plasminogen activator, or tPA, was found to help reduce post-stroke disability and mortality risk in patients with a hemorrhagic (bleeding) stroke. Two new studies based on the findings were presented at the stroke association's annual meeting in Los Angeles...
